The aim of this study was to verify the existence of synergistic antibacterial effect between four essential oils (Aniba rosaeodora, Melaleuca alternifolia, Origanum vulgare, and Pelargonium graveolens) individually combined with the antibacterial drug Gentamicin. We investigated the effectiveness in vitro of the association of essential oil/Gentamicin, against fifteen different strains of Gram positive and Gram negative bacteria. The antibacterial effects of these oils in combination with Gentamicin were evaluated by using the MHB microdilution method, while gas chromatography (GC) and GC/Mass spectrometry were used to analyze the chemical composition of the oils. A synergistic interaction was observed against all tested strains with the associations between the essential oils Aniba rosaeodora/Gentamicin and Pelargonium graveolens/Gentamicin. In particular a very strong synergistic interaction was observed against Acinetobacter baumannii ATCC 19606 (FIC index = 0.11). In contrast, the essential oils Origanum vulgare and Melaleuca alternifolia in association with Gentamicin were less effective on bacterial species growth. In vitro interaction can improve the antimicrobial effectiveness of the Gentamicin and may contribute to reduce its dose correlated to side effects.
INTRODUCTION
In the recent decades the antimicrobial research program focused its attention to search for newer compounds with potential antimicrobial activities, and worldwide spending on discovering new antimicrobial agents has increased in the last years. This real need is potentially ascribed both to the increasing emergence of bacterial resistance to antibiotic therapy and to newly emerging pathogens. Anyway, despite advances in antibacterial therapy, many problems remain to be solved for most available antimicrobial drugs. New source, especially the plant-derived antimicrobial compounds, are being investigated extensively in the recent years. In particular, a review of the recent literature revealed that among all natural products, plant essential oils are well known for their pharmacological activities, including antibacterial and antifungal activity, and may represent a promising source of new natural drugs [1] [2] [3] [4] [5] [6] [7] [8] . Essential oils have been largely employed for their properties already observed in nature, i.e. for their antibacterial, antifungal and insecticidal activities. At the present time, approximately 3000 essential oils are known, 300 of which are commercially available in the food, agronomic, sanitary and pharmaceutical areas. As the chemical profile of the essential oil products depends on the type of extraction and on the number of molecules extracted, therefore, it is very difficult to establish a specific biological target involved in the mechanism of action. Probably, their biological profiles are the result of a synergism of all molecules present in the oil or they reflect only those of the main molecules present at the highest levels as could be revealed by gas chromatography. For the same reasons, no particular resistance or adaptation to essential oils has been described [9] . It is important to underline that *Address correspondence to this author at the Pharmaceutical Chemistry Department, Università degli Studi di Bari, via Orabona 4, 70125, Bari, Italy; Tel: +39 080 5442728; Fax +39 080 5442724; E-mail: arosato@farmchim.uniba.it some of them constitute effective alternatives or complements to synthetic compounds without showing the same secondary effects [10] . All these observations prompted us to start a research program with the aim to develop a new highly active antibacterial therapeutic combination of essential oils and synthetic antibacterial agents in order to provide better efficacy for combating various infections and drug resistance [11] [12] [13] [14] [15] . Between aminoglicosides Gentamicin is widely used for the treatment and prevention of lifethreatening Gram-negative bacterial infections, but its several side effects limit its use.
The most relevant side effects are the toxicity to the sensory cells of the ear and nephrotoxicity. In addition, psychiatric symptoms related to Gentamicin (anorexia, confusion, depression, disorientation and visual hallucinations) can occur. Like all aminoglycosides, when Gentamicin is given orally, it is not systemically active. This is because it is not absorbed to any appreciable extent in the small intestine. It is administered intravenously, intramuscularly or topically to treat infections. It appears to be completely eliminated unchanged in the urine. Certain serious infections are conventionally treated with a prolonged dose of Gentamicin or other drugs. These include osteomyelitis, and endocarditis as well as serious and overwhelming infections.
In the present work we will discuss the in vitro association properties of Gentamicin and four essential oils extracted from Aniba rosaedora, Melaleuca alternifolia, Origanum vulgare, and Pelargonium graveolens against a large panel of Gram positive and Gram negative bacterial strains.
The antimicrobial activity of the four essential oils against different Gram positive and Gram negative bacterial strains and their synergistic effects when incorporated with Gentamicin were carried out by using the microdilution method.
EXPERIMENTAL SECTION

Material and Methods
The Eos (essential oils) EOs were purchased from Erbamea (Istrana, Treviso -Italy) and were obtained by steam distillation from Melalueca alternifolia (Tea Tree), Origanum vulgare (Wild majoran), Aniba rosaeodora (Rosewood), and Pelargonium graveolens (Fragrant geranium). The composition of the essential oils was analyzed using a gas chromatographer and mass spectrometer (GC-MS) composed of an HP 6890 and an HP 5973, equipped with an HP-5 capillary column [16] . [17] .
Bacterial Strains and Antimicrobial Testing
In our experimental procedure we applied some modifications to CLSI Protocol M7A6. A final volume concentration of 40% (v/v) stock solution with Tween 80, 0.1% of each essential oil in ethanol (1: 2.5) was diluted 1: 20 in MHB to obtain a 2% (v/v) solution. Doubling dilutions of the essential oil from 2% to 0.25% for all four of the essential oils were prepared directly in 96 well microtitre trays in MHB, (0.06% to 0.23% for Aniba rosaeodora, 0.01% to 0.45% for Pelargonium graveolens, 0.18% to 1.5% (v/v) for Melaleuca alternifolia, and 0.03% to 0.25% for Origanum vulgare). After the addition of 0.02 mL of inoculum, the trays were incubated at 36 °C for 24 hours. The final concentration of Ethanol was 3% (v/v). The MHB medium well control 0.1% (v/v) Tween 80 and Ethanol 3%, (but without essential oil) was used as a positive growth control. The suspensions obtained were adjusted to 0.5 McFarland in agreement with CLSI Protocol M7A6. Plates were incubated at 36 °C for 24 hours.
MIC was defined as the lowest concentration that did not result in any visible growth of the bacterial strains compared to their growth in the control well [18] . As reported in Table  1 MIC values are given in mg/mL and μg/mL for essential oils and Gentamicin respectively. MIC determinations were realized in triplicate in three independent assays. MIC data of the essential oils and Gentamicin were converted into Fractional Inhibitory Concentration (FIC) defined as ratio of the concentration of the antimicrobial in an inhibitory concentration with a second compound to the concentration of the antimicrobial by itself [19] . We decided to report the most interesting antimicrobial in Table 1 .
Microdilution Checkerboard Method
In the combination assays the checkerboard procedure described by White et al. [20] was followed to evaluate the synergistic action of the essential oils with Gentamicin. Twelve double serial dilutions of the four oils were prepared following the same method used to evaluate the MIC. Dilutions of the oil were prepared together with a series of double dilutions of the Gentamicin in the range of 16-0.25 g/mL. This method was used to mix all the Gentamicin dilutions with the appropriate concentrations of oil so that a series of concentration combinations of the Gentamicin/particular oil being considered were obtained. In our experimental protocol the substance combinations were analyzed by calculating the FIC index (FICI) as follows: FIC of oil plus FIC of Gentamicin. Generally, FICI value was interpreted as : i) a synergistic effect when 0.5; ii) an additive or indifferent effect when > 0.5 and < 1; iii) an antagonistic effect when > 1 [19] . The concentrations prepared accounted for 40%, 20%, 10%, and 5% of the MIC value for the oil, and 25%, 12.5%, 6.25%, 3.12% of the MIC value for the antibiotic. The combination of the two components can be shown graphically in a Cartesian diagram by applying the isobole method. The non-interaction of the two components results in a straight line, whereas the occurrence of an interaction is shown by a concave isobole [21] [22] [23] [24] [25] .
RESULTS
In this study four essential oils extracted from Aniba rosaedora, Melaleuca alternifolia, Origanum vulgare, and Pelargonium graveolens were used in association with Gentamicin. The effects of their combinations were evaluated on a large panel of Gram positive and Gram negative bacterial strains. The results for the interaction between the considered essential oils and Gentamicin are reported in Table 1 relatively to the most responsive bacterial strains. MICo (MIC of an individual sample) and MICc (MIC of an individual sample at the most effective combination) and FIC for Origanum vulgare, respectively, ranged from 0.3 to 0.6 mg/mL, 0.07 to 0.15 mg/mL, and 0.12 to 0.25 mg/mL. The MICo, MICc, and FIC of Aniba rosaeodora ranged from 0.25 to 2 mg/mL, 0.01 to 0.1 mg/mL, and 0.05 to 0.1 mg/mL, while the MICo, MICc, and FIC of Melaleuca alternifolia ranged from 1.7 to 13.8 mg/mL, 0.42 to 3.45 mg/mL, and 0.25 to 0.4 mg/mL. Furthermore, the MICo, MICc, and FIC of Pelargonium graveolens ranged from 0.12 to 1 mg/mL, 0.01 to 0.2 mg/mL, and 0.05 to 0.2 mg/mL respectively. Lastly, the MICo, MICc, and FIC of the Gentamicin ranged from 0.06 to 4 g/mL, 0.01 to 1.6 g /mL, and 0.03 to 0.4 g /mL respectively.
The best results from the evaluated oils in association with Gentamicin were obtained from Aniba rosaedora, and 2 and 3) describe the synergistic interaction between various oils and the antibiotic Gentamicin [25, 26] . The combination of the two components is shown by most common graphic representation called isobologram (iso-effect curve). It is worthy to note that an isobologram is constructed by outlining on the x and y axes, which are the inhibitory doses of two agents, for a given effect. If the effect is additive, the totaled doses are proportional to the effect, which is verified by a shift towards the straight line on the graph, which connects two doses with equal effects, a linear isobol, when the agents are not synergic. When the curve of the isobol moves towards the origin (concave line) this indicates that the agents in the mixture are synergic, and when the opposite occurs (convex line) they present antagonism. In the other words, the same biological effects of the agents in isolation is obtained at lower (or higher) doses of the mixture [27] . Because the synergistic effect of Gentamicin/Melaleuca alternifolia is not substantial, it is not reported on the graphs. Note how the isobole points of the Aniba rosaeodora and the Pelargonium graveolens (Fig. (1) ) are closer to the origin of the axes than the other two oils. The graphs indicate strong synergism against Staphylococcus aureus ATCC 6538p by the obviously deviating points to the left [28] Fig. (2) describes another interesting aspect of our work, the strongest synergistic efficacy of the mixture Gentamicin/Aniba rosaeodora or Pelargonium graveolens essential oils against Gram negative bacteria Acinetobacter baumannii ATCC 19606 with a FIC index equal to 0.11. Also, Fig. (3) shows strong synergistic effect against Escherichia coli ATCC 25922 with a FIC index equal to 0.35 that justify the interaction between the essential oil and Gentamicin. Figs. (1, 2 and 3) show that Aniba rosaeodora and Pelargonium graveolens essential oils have a high level of efficacy for their antibacterial ability. The synergistic antibacterial action demonstrated by combining either Melaleuca alternifolia (data not shown) or Origanum vulgare with Gentamicin was less pronounced or absent (Melaleuca alternifolia). To identify the composition of the tested oils, we analyzed the oils derived from the steam distillation of the four plant species by GC-MS [29] . The composition of these oils differs for the presence of some components as shown in Table 2 . The terpenalcohol fraction was the most prominent component in Aniba rosaeodora (74%) and Pelargonium graveolens (67%) essential oils, while this component is less present in Melaleuca alternifolia (38%) essential oil or completely absent in Origanum vulgare essential oil. Table 2 shows more phenolic compounds in Origanum vulgare, and more hydrocarbons in Melaleuca alternifolia. Table 1 reveals how the Gentamicin/Origanum vulgare association has an indifferent and non synergistic effect against five of the eight strains studied, and the Gentamicin/Melaleuca alternifolia association has an additive and non synergistic effect for the considered bacteria. In contrast, the effect of the Aniba rosaeodora and Pelargonium graveolens associations is always synergistic on all of the considered strains with an extreme FICI value of 0.11 for the Gram negative bacteria Acinetobacter baumanni ATCC 19606. Table 1 for the association of Aniba rosaeodora and Pelargonium graveolens with Gentamicin, are respectively in the range of 0.11-0.34 for all the studied bacterial strains. Furthermore, MIC Gentamicin is 
FICI values reported in
DISCUSSION
Essential oils are very complex natural mixtures which contain about 20-60 components at quite different concentrations. The components include two groups of distinct biosynthetical origin: the main group is composed of terpenes and terpenoids and the other aromatic and aliphatic constituents are all characterized by low molecular weight [30] . Regarding their biological properties they are the results of a synergism of all molecules or reflect only those of the main molecules present at the highest levels according to gas chromatographical analysis. In this study we report the antimicrobial activity of Gentamicin evaluated in association with four essential oils extracted by Aniba rosaedora, Melaleuca alternifolia, Origanum vulgare, and Pelargonium graveolens on a large panel of Gram positive and Gram negative bacterial strains.
The combination of Gentamicin/Pelargonium graveolens and Gentamicin/Aniba rosaeodora administered against the bacterial strains under consideration is likely to reduce Gentamicin minimum effect dose. In fact, as reported in Table 1 , Gentamicin MIC and FICI in combination with the above cited essential oils are particularly interesting against the studied Gram negative bacterial strains. It is important to underline the strong synergy observed between Gentamicin and Aniba rosaeodora against the Gram negative Acinetobacter baumannii. In detail, Gentamicin MICc is much lower than those normally required to show the direct inhibition of bacteria growth (MICc: 0.24 μg/mL vs MICo: 4 μg/mL).
To elucidate the mechanism of action on the basis of the synergism of Gentamicin/essential oils and in particular Gentamicin/Pelargonium graveolens and Gentamicin/Aniba rosaeodora is very difficult. For this purpose different hypothesis should be taken into account. All interactions between antimicrobial compounds can alter effectiveness and synergistic or antagonistic relationships may result in competition for possible primary target [31] . On the other hand, a synergistic multi-target effect could occur by involving enzymes, substrates, metabolites and proteins, receptors, ion channels, transport protein, ribosomes, DNA/RNA and physicochemical mechanism [32] .
Alternatively, interaction between different compounds may lead to changes in structural conformation, thus resulting in the reduction of the inhibitory activity [33] .
Because there could be a lot of potential mechanism of action on the basis of a synergistic effect at the beginning of this research program, thus we were unable to investigate the exact mechanism of action. We hypothesized to rationalize the contribution of each essential oil in association with Gentamicin by evaluating different chemical compositions of the cited essential oils as reported by gas chromatographic analysis ( Table 2) . As suggested by Table 2 , the antimicrobial activity and so the synergistic effect of Pelargonium graveolens and Aniba rosaeodora, could be attributed to the high percentage of terpenalcohols that former represent the major component of both oils. At this purpose, recent literature studies suggest that monoterpenes contained in essential oils interact with model membranes and their antimicrobial effect may be ascribed to a damage of the microbial lipid membrane fraction [34] . In relation to the lipid composition and the net surface charge of the microbial membrane, the Gram negative outer membrane has a strong negative charge conferred by the lipopolisaccharide.
All these considerations prompted us to hypothesize that the high level of terpenalcohols in Pelargonium graveolens (63%) and Aniba rosaeodora (73%) favours the Gentamicin mechanism of action whose main effect is to interrupt the protein synthesis by binding the 30S subunit of bacteria ribosome.
In conclusion, here we have shown that in vitro association of Gentamicin/ Pelargonium graveolens and Gentamicin/Aniba rosaeodora is particularly interesting against Gram negative bacteria. In detail, this association was found to produce a substantial Gentamicin MIC reduction against Acinetobacter baumannii, a Gram negative bacteria whose pharmacological treatment is very difficult nowadays. Thus, these important results may help the formulation of new topical agents for the cure of infections caused by the Gram negative bacteria.
Finally, we suppose that this work could provide a platform for active researchers to perform further experimental procedures to provide greater details about the mechanism of action of the synergism so as to plan clinical trial to confirm these in vitro results.
